TrialJAMA oncology2018

Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.

Mary Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.